Paul D. Bates

Also affiliated with University of Wisconsin Carbone Cancer Center

Immunology and MicrobiologyMedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 8 papers. Top paper: “Targeting DNMT3A-mediated oxidative phosphorylation to overcome ibrutinib resistance in mantle cell lymphoma”.

Targeting DNMT3A-mediated oxidative phosphorylation to overcome ibrutinib resistance in mantle cell lymphoma

Cell Reports Medicine(2024)10.1016/j.xcrm.2024.101484

N/A

0.416DataRank · unranked

15 citations

Yunxia Liu, Paul D. Bates, Alexa R. Heaton, Angelica F. Lopez, Peng Liu +10 more

CD155 blockade enhances allogeneic natural killer cell-mediated antitumor response against osteosarcoma

Journal for ImmunoTherapy of Cancer(2025)10.1136/jitc-2023-008755

N/A

0.398DataRank · unranked

9 citations

Longzhen Song, Aicha Quamine, Fernanda Szewc, Lei Shi, Johnathan Ebben +12 more

Dichotomic Potency of IFNγ Licensed Allogeneic Mesenchymal Stromal Cells in Animal Models of Acute Radiation Syndrome and Graft Versus Host Disease

Frontiers in Immunology(2021)10.3389/fimmu.2021.708950

N/A

0DataRank · unranked

15 citations

Paul D. Bates, Keith A. Kunugi, Kwangok P. Nickel, Larry A. DeWerd, Christian M. Capitini +3 more

373 Combination vaccine, adoptive NK cell transfer and checkpoint blockade reduce murine neuroblastoma progression after bone marrow transplant

Regular and Young Investigator Award Abstracts(2022)10.1136/jitc-2022-sitc2022.0373

N/A

0DataRank · unranked

1 citations

Nicholas R Mohrdieck, Chloe King, Anastasia A Griggs, Paul D. Bates, Sean Rinella +5 more

382 TIM-3 blockade combined with adoptive therapy of ex vivo activated NK cells after allogeneic hematopoietic stem cell transplant reduces progression of relapsed murine neuroblastoma

Regular and Young Investigator Award Abstracts(2023)10.1136/jitc-2023-sitc2023.0382

N/A

0DataRank · unranked

0 citations

Nicholas R Mohrdieck, Chloe King, Anastasia A Griggs, Katharine E. Tippins, Paul D. Bates +5 more

Combining Immunocytokine and Ex Vivo Activated NK Cells as a Platform for Enhancing Graft-Versus-Tumor Effects Against GD2+ Murine Neuroblastoma

Frontiers in Immunology(2021)10.3389/fimmu.2021.668307

N/A

0DataRank · unranked

12 citations

Alexander L. Rakhmilevich, Monica M. Cho, Myriam N. Bouchlaka, Seema L. Rao, Joanna M. Hales +6 more

TIM-3 blockade enhances ex vivo stimulated allogeneic NK cell therapy for relapsed murine neuroblastoma after hematopoietic cell transplant

Journal for ImmunoTherapy of Cancer(2025)10.1136/jitc-2024-010239

N/A

0DataRank · unranked

1 citations

Evan L. Dray, Nicholas R Mohrdieck, Chloe King, Anastasia A Griggs, Jillian M Kline +11 more

EGR1 Addiction in Diffuse Large B-cell Lymphoma

Molecular Cancer Research(2021)10.1158/1541-7786.mcr-21-0267

N/A

0DataRank · unranked

16 citations

Li Lü, Nguyet M. Hoang, Fen Zhu, Paul D. Bates, Anusara Daenthanasanmak +13 more